Ambev S.A. shares in São Paulo managed to hold onto most of their post-earnings gains as the new trading week began, despite a modest pullback on Friday. The brewer's stock, listed under ticker ABEV3, slipped 1.83% on May 22 to close at 16.10 reais. However, the stock still posted a 2.6% gain from the previous Friday, reflecting investor optimism following the company's first-quarter results.
The timing of the market calendar adds a layer of complexity. Brazil's B3 exchange was closed over the weekend, while the New York Stock Exchange will be shut on Monday for Memorial Day. This means Ambev shares in São Paulo can trade on Monday before the company's American Depositary Receipts (ADRs) resume trading in the U.S. on Tuesday. The ADRs ended the week at $3.20, up 4.2%.
Ambev's first-quarter earnings, released on May 5, remain the primary driver of investor sentiment. Organic net revenue rose 8.1%, while normalized EBITDA increased 10.1%, with the EBITDA margin expanding by 60 basis points to 33.6%. CEO Carlos Lisboa described the quarter as "a solid start to 2026," citing stronger beer volumes, double-digit EBITDA growth, and margin improvements.
Importantly, volume growth was not the main catalyst. Total beer volume edged up just 0.1% organically. Instead, the company generated more revenue per hectoliter, with Brazil Beer sales improving and margins benefiting from better execution and product mix. This operational discipline helped offset a challenging cost environment.
Cash flow saw a dramatic improvement. Operating cash flow surged 162.5% year-over-year to 3.16 billion reais. The board approved a 1.2 billion-real interest-on-capital payout, scheduled for July 6, along with an additional distribution of about 700 million reais due by December. Interest on capital is a tax-efficient form of shareholder return in Brazil.
The broader market backdrop provided little support. The Ibovespa index dropped 0.81% on Friday to 176,209.61, ending the week down 0.61%. Ambev's performance was largely driven by stock-specific factors rather than a broader Brazilian market rally.
UBS analyst Rodrigo Alcantara maintained a Sell rating on Ambev but raised his price target to $2.90 from $2.65, still below the ADR's Friday close of $3.20. This suggests the market may have already priced in most of the upside from the earnings report. The company reported an 8.5% increase in cash cost of goods sold per hectoliter, citing foreign-exchange and commodity pressures, and kept its Brazil Beer cost outlook steady at a 4.5% to 7.5% rise for the year.
Looking ahead, the next few sessions will test whether the stock can sustain its gains. With U.S. markets closed Monday, Brazilian investors will have the first opportunity to react to any new developments. Key factors to watch include movements in the Brazilian real and any shifts in consumer sentiment or beer volume trends. If the Ibovespa continues to slide or if traders conclude that the post-earnings rally has overshot the company's near-term cost and volume prospects, Ambev could face headwinds. For now, the stock remains buoyed by solid fundamentals and a supportive payout policy.